John M. Pietruski
Director/Board Member at Xylos Corp.
Profile
John M.
Pietruski is currently a Director at Xylos Corp.
He was previously the Chairman & CEO at Sterling Drug, Inc. from 1977 to 1988, and the Chairman at Encysive Pharmaceuticals, Inc. from 1990 to 2008.
He also served as a Director at Interpace Biosciences, Inc. from 1998 to 2010 and is currently a Director at FirstEnergy Corp.
Mr. Pietruski received his undergraduate degree from Rutgers State University of New Jersey in 1954.
John M. Pietruski active positions
Companies | Position | Start |
---|---|---|
Xylos Corp.
Xylos Corp. BiotechnologyHealth Technology Xylos Corp. provides biotechnology solutions. The firm operates as a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. The company was founded by Gonzalo C. Serafica in 1996 and is headquartered in Newtown, PA. | Director/Board Member | 01/12/2001 |
Former positions of John M. Pietruski
Companies | Position | End |
---|---|---|
INTERPACE BIOSCIENCES, INC. | Director/Board Member | 01/05/2010 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Chairman | 01/04/2008 |
Sterling Drug, Inc. | Chairman | 01/01/1988 |
Mercalis, Inc.
Mercalis, Inc. Information Technology ServicesTechnology Services TrialCard, Inc. provides customer related solutions to pharma industry. It offers analytics, customer experience management, patient affordability, pharmacy, product access support and tailored services which include adherence measures, business intelligence case management and navigation services. The company was founded by David Cunningham in 2000 and is headquartered in Morrisville, NC. | Director/Board Member | - |
FIRSTENERGY CORP. | Director/Board Member | - |
Training of John M. Pietruski
Rutgers State University of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
FIRSTENERGY CORP. | Utilities |
INTERPACE BIOSCIENCES, INC. | Health Technology |
Private companies | 4 |
---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Mercalis, Inc.
Mercalis, Inc. Information Technology ServicesTechnology Services TrialCard, Inc. provides customer related solutions to pharma industry. It offers analytics, customer experience management, patient affordability, pharmacy, product access support and tailored services which include adherence measures, business intelligence case management and navigation services. The company was founded by David Cunningham in 2000 and is headquartered in Morrisville, NC. | Technology Services |
Xylos Corp.
Xylos Corp. BiotechnologyHealth Technology Xylos Corp. provides biotechnology solutions. The firm operates as a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. The company was founded by Gonzalo C. Serafica in 1996 and is headquartered in Newtown, PA. | Health Technology |
Sterling Drug, Inc. | Consumer Non-Durables |
- Stock Market
- Insiders
- John M. Pietruski